tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Technical Analysis

Compare
517 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is -0.59, suggesting ARS Pharmaceuticals is a Sell.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 10.40, while ARS Pharmaceuticals’s (SPRY) share price is $10.27, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 12.00, while ARS Pharmaceuticals’s (SPRY) share price is $10.27, making it a Sell.

ARS Pharmaceuticals (SPRY) Pivot Points

Oct 08, 2025, 03:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.62
9.84
10.05
10.27
10.48
10.70
10.91
Fibonacci
9.84
10.00
10.10
10.27
10.43
10.53
10.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Oct 08, 2025, 03:44 PM
Period
Simple
Exponential
MA5
10.26Buy
10.23Buy
MA10
10.00Buy
10.13Buy
MA20
9.95Buy
10.40Sell
MA50
12.71Sell
12.00Sell
MA100
14.37Sell
13.18Sell
MA200
13.43Sell
13.25Sell
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 10.13, while ARS Pharmaceuticals’s (SPRY) share price is $10.27, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 13.18, while ARS Pharmaceuticals’s (SPRY) share price is $10.27, making it a Sell.
ARS Pharmaceuticals’s (SPRY) stock price is $10.27 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 12.71, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $10.27 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 14.37, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $10.27 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 13.43, creating a Sell signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Oct 08, 2025, 03:44 PM
Name
Value
Implied Action
RSI (14)
42.36
Neutral
STOCH (9,6)
57.13
Neutral
STOCHRSI (14)
57.13
Neutral
MACD (12,26)
-0.59
Sell
ADX (14)
33.25
Neutral
Williams %R
-41.30
Buy
CCI (14)
78.28
Neutral
ATR (14)
0.64
-
Ultimate Oscillator
42.39
Neutral
ROC
7.94
Buy
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 42.36, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 33.25, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is 78.28, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is 7.94, creating a Buy signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Hold.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 42.36, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is -0.59, which suggests SPRY is a Sell.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 10.26, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 9.95, which suggests SPRY is a Buy.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 12.71, which suggests SPRY is a Sell.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 13.43, which suggests SPRY is a Sell.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -41.30, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is 78.28, which suggests SPRY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis